| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681112 | Basal Ganglia | 2018 | 13 Pages |
Abstract
In the study the considerable proportion of MSA-P patients received high levels of dopaminergic medication chronically. Its efficacy on MSA is still uncertain and further studies with standardised clinical efficacy monitoring are highly welcome.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sarunas Augustis, Wolfgang H. Jost,